StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$390.30−6.39 (-1.61%)

Close on Nov 20, 2026Market cap $27.19BP/E 43.8Yield 0.22%

West Pharmaceutical Services Ongoing EU GMP Annex 1 / HVP Customer Upgrade Projects by Quarter

West Pharmaceutical Services Ongoing EU GMP Annex 1 / HVP Customer Upgrade Projects: 325 in Q4 2025.

Latest, Q4 2025
325
Period ended Dec 31, 2025
Change on a year earlier
–
History
4 quarters
Since Q1 2025
Sources
3
Documents cited below

Where the Q4 2025 figure comes from

“325 projects are ongoing”

Source: West Form 8-K (FY2025Q4, filed 2026-02-12) ↗

Active customer conversion projects upgrading standard stoppers and seals to Westar/NovaPure/FluroTec High-Value Products under EU GMP Annex 1 sterility rules.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOngoing EU GMP Annex 1 / HVP Customer Upgrade ProjectsYear on yearSource
Q4 2025Dec 31, 2025325–West Form 8-K (FY2025Q4, filed 2026-02-12) ↗
Q3 2025Sep 30, 2025375–West Form 8-K (FY2025Q3, filed 2025-10-23) ↗
Q2 2025Jun 30, 2025370–West Form 8-K (FY2025Q2, filed 2025-07-24) ↗
Q1 2025Mar 31, 2025340–West Form 8-K (FY2025Q2, filed 2025-07-24) ↗

Cite this data

StockData. (2026). West Pharmaceutical Services Ongoing EU GMP Annex 1 / HVP Customer Upgrade Projects, quarterly Q1 2025–Q4 2025 [Data set]. Compiled from West Pharmaceutical Services SEC filings and investor materials. https://stockdatahq.com/stocks/wst/kpis/annex1-ongoing-projects

See every metric in the West Pharmaceutical Services KPI table. Data updated Nov 9, 2026.

See a number that looks wrong?